Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Participants randomized (1:1:1) to treatment groups will be term or near-term infants with isoimmune hemolytic disease or glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted